Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective - Hernando, C; Ortega-Morillo, B; Tapia, M (Int J Mol Sci, 2021)
et al.